Source: Haematologica. Unidade: FMRP
Subjects: LEUCEMIA MIELOIDE AGUDA, POLIMORFISMO, GENES SUPRESSORES DE TUMOR
ABNT
BEZERRA, Matheus F. et al. Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia. Haematologica, v. 102, n. 2, p. e43-e46, 2017Tradução . . Disponível em: https://doi.org/10.3324/haematol.2016.155069. Acesso em: 02 nov. 2024.APA
Bezerra, M. F., Coelho-Silva, J. L., Nascimento, J. C., Benicio, M. T., Rocha, C. R., Machado, C. G., et al. (2017). Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia. Haematologica, 102( 2), e43-e46. doi:10.3324/haematol.2016.155069NLM
Bezerra MF, Coelho-Silva JL, Nascimento JC, Benicio MT, Rocha CR, Machado CG, Rego EM, Bezerra MA, Lucena-Araújo AR, Beltrão EIC. Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia [Internet]. Haematologica. 2017 ; 102( 2): e43-e46.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3324/haematol.2016.155069Vancouver
Bezerra MF, Coelho-Silva JL, Nascimento JC, Benicio MT, Rocha CR, Machado CG, Rego EM, Bezerra MA, Lucena-Araújo AR, Beltrão EIC. Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia [Internet]. Haematologica. 2017 ; 102( 2): e43-e46.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3324/haematol.2016.155069